ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BYRON LITTLEFIELD D.O.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 1677

$1.05M Total Retail Price of All Prescriptions

Rank: 63 out of 1677

615 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 615 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 615 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,837 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,060 660 S3 1 4
LEVOTHYROXINE SODIUM 774 593 2 5
LISINOPRIL 770 518 3 3
SIMVASTATIN 719 497 4 1
AMLODIPINE BESYLATE 611 501 5 2
OMEPRAZOLE 537 303 6 6
FUROSEMIDE 534 384 7 8
PRAVASTATIN SODIUM 527 350 8 10
METOPROLOL TARTRATE 519 331 9 12
METFORMIN HCL 499 298 10 7
POTASSIUM CHLORIDE 424 289 11 14
ATORVASTATIN CALCIUM 407 264 12 13
GLIMEPIRIDE 390 270 13 33
RANITIDINE HCL 324 197 14 18
ATENOLOL 310 208 15 21
ZOLPIDEM TARTRATE 305 211 16 15
NEXIUM 297 198 17 19
GABAPENTIN 273 121 18 11
TRAMADOL HCL 265 203 19 16
AZITHROMYCIN 244 160 20 38
HYDROCHLOROTHIAZIDE 242 156 21 9
SERTRALINE HCL 242 149 21 26
PROMETHAZINE HCL 233 56 R 23 64
PAROXETINE HCL 228 146 24 67
FLUOXETINE HCL 207 117 25 49
WARFARIN SODIUM 196 163 26 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 151 27 17
PANTOPRAZOLE SODIUM 193 152 28 46
METOPROLOL SUCCINATE 187 124 29 23
DONEPEZIL HCL 186 171 30 30
BISOPROLOL-HYDROCHLOROTHIAZIDE 182 139 31 107
TRAZODONE HCL 177 93 32 37
DICLOFENAC SODIUM 171 104 33 95
TRIAMTERENE-HCTZ 161 94 34 61
CRESTOR 158 99 35 28
CYMBALTA 156 102 36 58
VENLAFAXINE HCL ER 153 47 37 92
MELOXICAM 150 98 38 27
AMITRIPTYLINE HCL 144 120 R 39 63
CLOPIDOGREL 144 89 39 32
ENDOCET 139 42 S2 41 114
BENAZEPRIL HCL 138 81 42 53
ADVAIR DISKUS 138 81 42 54
ALLOPURINOL 136 74 44 31
FLUTICASONE PROPIONATE 133 78 45 29
ISOSORBIDE MONONITRATE ER 130 103 46 73
TAMSULOSIN HCL 128 113 47 34
COMBIVENT 127 67 48 105
LEVOFLOXACIN 126 62 49 84
PREDNISONE 123 73 50 40
PROAIR HFA 122 59 51 50
FENOFIBRATE 118 69 52 48
PLAVIX 111 78 53 47
CYCLOBENZAPRINE HCL 108 42 R 54 52
PREMARIN 107 38 R 55 109
PRAMIPEXOLE DIHYDROCHLORIDE 106 64 56 172
NAMENDA 105 84 57 39
DIGOXIN 104 97 58 71
TOPIRAMATE 100 52 59 181
CARVEDILOL 100 84 59 20
LOVASTATIN 99 82 61 35
MECLIZINE HCL 97 86 62 110
CARBIDOPA-LEVODOPA 95 53 63 131
ESTRADIOL 93 57 R 64 129
NADOLOL 85 32 65 284
SPIRIVA 83 28 66 74
MIRTAZAPINE 81 53 67 62
RISPERIDONE 79 34 68 60
LANTUS SOLOSTAR 78 31 69 132
TERAZOSIN HCL 76 71 70 138
NIFEDIPINE ER 76 63 70 98
TRICOR 75 32 72 100
ALPRAZOLAM 75 62 72 153
LANSOPRAZOLE 74 43 74 147
LIPITOR 73 41 75 101
VENTOLIN HFA 73 44 75 89
FENTANYL 72 13 S2 77 103
AMLODIPINE BESYLATE-BENAZEPRIL 72 65 77 59
LOSARTAN POTASSIUM 72 56 77 25
CLONIDINE HCL 71 37 80 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 31 81 85
METHYLPREDNISOLONE 68 40 82 145
GLIPIZIDE ER 66 53 83 78
ALENDRONATE SODIUM 64 64 84 43
CLONAZEPAM 64 51 84 275
AMOX TR-POTASSIUM CLAVULANATE 63 39 86 126
BUSPIRONE HCL 63 17 86 120
NAPROXEN 62 56 88 87
SINGULAIR 62 35 88 97
DILTIAZEM 24HR CD 62 50 88 156
IBUPROFEN 61 37 91 83
JANUVIA 61 33 91 70
SYNTHROID 59 32 93 55
LANTUS 59 42 93 44
BETAMETHASONE DIPROPIONATE 57 41 95 404
GLIPIZIDE XL 57 53 95 123
SPIRONOLACTONE 57 35 95 88
PHENYTOIN SODIUM EXTENDED 56 31 98 112
DOXAZOSIN MESYLATE 56 55 98 90
ROPINIROLE HCL 53 38 100 79
TORSEMIDE 52 11 101 152
SUMATRIPTAN SUCCINATE 51 18 102 308
NITROFURANTOIN MONO-MACRO 51 43 102 177
ESCITALOPRAM OXALATE 50 28 104 80
CEPHALEXIN 50 39 104 99
DIOVAN HCT 50 50 104 66
QUETIAPINE FUMARATE 50 17 104 77
ZETIA 50 19 104 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.